These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3573416)

  • 1. Estimation of harmine and its derivatives by HPLC: correlation of brain harmine levels with jumping behavior in rats.
    Moroi K; Kuga T
    Jpn J Pharmacol; 1987 Jan; 43(1):33-41. PubMed ID: 3573416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of brain monoamine systems in the jumping behavior induced in rats by the combination of harmine and apomorphine.
    Takashi K; Kuga T
    Jpn J Pharmacol; 1981 Oct; 31(5):677-88. PubMed ID: 6458722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of GABAergic systems and benzodiazepine receptors in the jumping behavior induced by harmine and apomorphine in rats.
    Moroi K; Takashi K; Kuga T
    Jpn J Pharmacol; 1988 Aug; 47(4):367-78. PubMed ID: 2846933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection.
    Moncrieff J
    J Chromatogr; 1989 Nov; 496(2):269-78. PubMed ID: 2613832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of harmane and other β-carbolines on apomorphine-induced licking behavior in rat.
    Farzin D; Haghparast A; Motaman S; Baryar F; Mansouri N
    Pharmacol Biochem Behav; 2011 Apr; 98(2):215-9. PubMed ID: 21237191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of harmine and brain lesions on apomorphine induced motor activity.
    Westermann KH; Funk K; Pawlowski L
    Pharmacol Biochem Behav; 1976 Jan; 4(1):1-6. PubMed ID: 131324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a distinct class of high-affinity binding sites for [3H]norharman [( 3H]beta-carboline) in the rat brain.
    Pawlik M; Rommelspacher H
    Eur J Pharmacol; 1988 Mar; 147(2):163-71. PubMed ID: 3366173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites.
    Tweedie DJ; Burke MD
    Drug Metab Dispos; 1987; 15(1):74-81. PubMed ID: 2881762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harman in rat brain, lung and human CSF: effect of alcohol consumption.
    Bosin TR; Borg S; Faull KF
    Alcohol; 1988; 5(6):505-11. PubMed ID: 3245894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicokinetics of tremorogenic natural products, harmane and harmine, in male Sprague-Dawley rats.
    Guan Y; Louis ED; Zheng W
    J Toxicol Environ Health A; 2001 Dec; 64(8):645-60. PubMed ID: 11766171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
    May T; Greube A; Strauss S; Heineke D; Lehmann J; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a correlation between the concentration of beta-carbolines and their pharmacodynamic effects?
    Rommelspacher H; Barbey M; Strauss S; Greiner B; Fähndrich E
    Prog Clin Biol Res; 1982; 90():41-55. PubMed ID: 6287495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic aspects of the comutagenic action of norharman.
    Sugimura T; Nagao M; Wakabayashi K
    Adv Exp Med Biol; 1981; 136 Pt B():1011-25. PubMed ID: 7046384
    [No Abstract]   [Full Text] [Related]  

  • 15. On the neuropharmacology of harmane and other beta-carbolines.
    Müller WE; Fehske KJ; Borbe HO; Wollert U; Nanz C; Rommelspacher H
    Pharmacol Biochem Behav; 1981 May; 14(5):693-9. PubMed ID: 6264501
    [No Abstract]   [Full Text] [Related]  

  • 16. Kindling of seizures with norharman, a beta-carboline ligand of benzodiazepine receptors.
    Morin AM; Watson AL; Wasterlain CG
    Eur J Pharmacol; 1983 Mar; 88(1):131-4. PubMed ID: 6303806
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of induction on the metabolism and cytochrome P-450 binding of harman and other beta-carbolines.
    Tweedie DJ; Prough RA; Burke MD
    Xenobiotica; 1988 Jul; 18(7):785-96. PubMed ID: 3176517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test.
    Farzin D; Mansouri N
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):324-8. PubMed ID: 16183262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Zhao T; Zheng SS; Zhang BF; Li YY; Bligh SW; Wang CH; Wang ZT
    Food Chem; 2012 Sep; 134(2):1096-105. PubMed ID: 23107733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies on the effect of beta-carbolines on the activities of acetylcholinesterase and choline acetyltransferase and on the muscarinic receptor binding of the rat brain.
    Skup M; Oderfeld-Nowak B; Rommelspacher H
    J Neurochem; 1983 Jul; 41(1):62-8. PubMed ID: 6864229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.